Related Experiment Video

Updated: Apr 4, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.9K

MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma

Hao Yang1,2, Wei Zheng1, Xiao Shuai1

  • 1Liver Cancer Laboratory, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.

Oncotarget
|August 29, 2015
PubMed

Insights

MicroRNA-424 (miR-424) is decreased in hepatocellular carcinoma (HCC), suppressing tumor growth by inhibiting the pRb-E2F pathway. Its levels predict patient survival, suggesting miR-424 as a potential biomarker for HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern with complex molecular underpinnings.
  • MicroRNAs (miRNAs) play critical roles in cancer development and progression.
  • Identifying novel molecular players in HCC is crucial for therapeutic advancements.

Purpose of the Study:

  • To investigate the role of miR-424 in hepatocellular carcinoma (HCC).
  • To elucidate the molecular mechanisms by which miR-424 affects HCC.
  • To evaluate miR-424 as a potential prognostic biomarker for HCC.

Main Methods:

  • Differential expression profiling of miRNAs in HCC tissues and cell lines.
  • In vivo and in vitro assays to assess the effect of miR-424 on HCC cell proliferation.
  • Multi-pathway reporter arrays to identify target pathways.
  • Western blotting and siRNA/overexpression studies to validate molecular targets (Akt3, E2F3).

Main Results:

  • miR-424 expression was significantly downregulated in HCC tissues and cell lines.
  • Reduced miR-424 levels correlated with advanced tumor stage, vein invasion, and poorer overall survival.
  • Upregulation of miR-424 suppressed HCC cell proliferation by inhibiting the pRb-E2F pathway.
  • Akt3 and E2F3 were identified as direct targets of miR-424.

Conclusions:

  • miR-424 acts as a tumor suppressor in HCC development and progression.
  • miR-424 influences HCC growth through the pRb-E2F pathway by targeting Akt3 and E2F3.
  • miR-424 holds promise as a valuable prognostic biomarker for HCC.
Keywords:
Akt3E2F3hepatocellular carcinomamiR-424tumor growth

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

18.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K